| 294 | 48 | 127 |
| 下载次数 | 被引频次 | 阅读次数 |
目的观察中晚期胃癌患者术后化疗联合黄芪颗粒治疗对其生活质量和免疫功能的影响。方法将67例中晚期胃癌患者随机分为联合化疗组(n=37)和单纯化疗组(n=30),对两组中晚期胃癌患者术后治疗的疗效、生活质量、毒副作用和免疫功能等进行比较。结果临床研究结果显示,联合化疗组胃癌患者总有效率显著高于单纯化疗组(P<0.05),且联合化疗组胃癌患者其生活质量明显优于单纯化疗组(P<0.05)。另外,联合化疗组胃癌患者消化道反应和骨髓抑制作用的毒副作用的发生率低,且毒副作用程度轻,同时联合化疗组胃癌患者免疫功能较单纯化疗组明显改善(P<0.05)。结论胃癌患者化疗联合黄芪颗粒治疗可明显提高临床疗效和患者生活质量,同时改善患者免疫功能,减轻化疗的毒副作用。
Abstract:Objective To evaluate the effect of a combination of Huangqikeli and chemotherapy on the quality of life and immune function in postoperative patients with gastric cancer.Methods 67 cases of gastric cancer patients were randomly assigned into Huangqikeli group(n = 37,FOLFOX4 regimen + Huangqikeli) and control group(n= 30,FOLFOX4 regimen alone).The recent effect,life quality,toxic reaction and immune function were observed.Results Huangqikeli potentiated the therapeutic effect of chemotherapy on alleviation of postoperative symptoms and improvement of the quality of life in patients with gastric cancer.Addition of Huanqikeli also increased the counts of CD3+,CD4+,CD8+T cells and NK cells,suggesting an improvement in immune function.Conclusion Addiction of Huangqikeli in postoperative patients with gastric cancer receiving chemotherapy can reduce the toxicity of chemotherapy and improve immune function.
[1]何裕隆.胃癌病理分型研究进展[J].中国实用外科杂志,2005,25(7):438-40.
[2]Nakajima T.Gastric cancer treatment guidelines in Japan[J].Gastric Cancer,2002,5(1):1-5.
[3]徐丽,丁秀芹.胃癌患者化疗期应用黄芪联合丹参注射液疗效分析[J].中国实用医药,2013,8(2):21-2.
[4]刘昕,花宝金.中医药治疗对进展期胃癌患者生活质量和生存期的影响[J].中国中西医结合杂志,2008,28(2):105-7.
[5]袁嘉敏,余齐鸣,凌志强.胃癌外周血淋巴细胞亚群表达水平对患者生存率的影响[J].中华胃肠外科杂志,2011,14(10):796-8.
[6]陈国健,程霞,李坊铭,等.T淋巴细胞亚群测定与鼻咽癌预后关系的探讨[J].中华肿瘤防治杂志,2010,17(8):627-8.
[7]陈智敏,侯轶.胃癌患者外周血淋巴细胞免疫功能分析[J].中国医药导报,2013,10(4):30-3.
[8]D'Acquisto F,Crompton T.CD3+D4-CD8-(double negative)T cells:saviours or villains of the immune response[J].Biochem Pharmacol,2011,82(4):333-40.
[9]Kim E Y,Juvet S C,Zhang L.Regulatory CD4(-)CD8(-)double negative T cells[J].Methods Mol Biol,2011,677:85-98.
[10]Cho W C,Leung K N.In vitro and in vivo immunomodulating and immunorestorative effects of astragalus membranaceus[J].J Ethnopharmacol,2007,113(1):132-41.
[11]Cho W C,Leung K N.In vitro and in vivo anti-tumor effects of Astragalus membranaceus[J].Cancer Lett,2007,252(1):43-54.
[12]许杜娟,陈敏珠.黄芪多糖的抑瘤作用及其机制[J].中国医院药学杂志,2005,25(10):923-5.
基本信息:
DOI:10.19405/j.cnki.issn1000-1492.2014.12.020
中图分类号:R735.2
引用信息:
[1]汪正广,齐东江,李嘉嘉,等.中晚期胃癌患者术后化疗联合黄芪颗粒治疗对生活质量及免疫功能的影响[J].安徽医科大学学报,2014,49(12):1771-1774.DOI:10.19405/j.cnki.issn1000-1492.2014.12.020.
基金信息:
安徽省科技厅2013-2014年度科技攻关计划项目(编号:1301043054)
2014-12-23
2014-12-23